Why spinal cord stimulation, rTMS, and neuropathic pain assessments demand indication-specific comparators, credible long-term outcomes, and a pathway from clinical evidence to funding. Spain and France are scrutinising neuromodulation from …

A practical evidence and health-economic framework for measuring pathway change, released clinical capacity, performance-based payment and value capture. 29 September 2026 1. The economic question has been framed too narrowly …

Why Static Cost-Effectiveness Models Fall Short A lifecycle approach to evidence, health economics, AI, implementation and market access 29 September 2026 The economic value of a digital technology is not …

On 23 July 2026, France’s Haute Autorité de Santé announced the creation of MiMED — Mission Méthodes, Europe, Données. MiMED is an expansion of the Cellule de coordination des données …

What reconstructed patient-level survival data can and cannot tell us Odelle Technology  |  September 2026 A Kaplan-Meier curve is not merely a picture. It contains enough structured information that, under …

What metastatic pancreatic cancer reveals about patient choice, real-world evidence and the denominator Two contemporary datasets appear to describe radically different treatment uptake in metastatic pancreatic cancer: 72% untreated in …